{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:58:49Z","timestamp":1787241529766,"version":"build-2736575974"},"reference-count":49,"publisher":"BMJ","issue":"10","funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C8640\/A23385"],"award-info":[{"award-number":["C8640\/A23385"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203921\/Z\/16\/Z"],"award-info":[{"award-number":["203921\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,7,24]]},"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>In urological cancers, sex disparity exists for survival, with women doing worse than men. Suboptimal evaluation of presenting symptoms may contribute.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We performed a systematic review examining factors affecting the quality of the diagnostic process of patients presenting with symptoms of bladder or kidney cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>We searched Medline, Embase and the Cochrane Library from 1 January 2000 to 13 June 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligible criteria<\/jats:title>\n                    <jats:p>We focused on one of the six domains of quality of healthcare: timeliness, and examined the quality of the diagnostic process more broadly, by assessing whether guideline-concordant history, examination, tests and referrals were performed. Studies describing the factors that affect the timeliness or quality of the assessment of urinary tract infections, haematuria and lower urinary tract symptoms in the context of bladder or kidney cancer, were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>Data extraction and quality assessment were independently performed by two authors. Due to the heterogeneity of study design and outcomes, the results could not be pooled. A narrative synthesis was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>28 studies met review criteria, representing 583 636 people from 9 high-income countries. Studies were based in primary care (n=8), specialty care (n=12), or both (n=8). Up to two-thirds of patients with haematuria received no further evaluation in the 6 months after their initial visit. Urinary tract infections, nephrolithiasis and benign prostatic conditions before cancer diagnosis were associated with diagnostic delay. Women were more likely to experience diagnostic delay than men. Patients who first saw a urologist were less likely to experience delayed evaluation and cancer diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Women, and patients with non-cancerous urological diagnoses just prior to their cancer diagnosis, were more likely to experience lower quality diagnostic processes. Risk prediction tools, and improving guideline ambiguity, may improve outcomes and reduce sex disparity in survival for these cancers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2019-029143","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T07:29:13Z","timestamp":1570174153000},"page":"e029143","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Quality of the diagnostic process in patients presenting with symptoms suggestive of bladder or kidney cancer: a systematic review"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8815-1457","authenticated-orcid":false,"given":"Yin","family":"Zhou","sequence":"first","affiliation":[{"name":"Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije","family":"van Melle","sequence":"additional","affiliation":[{"name":"Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardeep","family":"Singh","sequence":"additional","affiliation":[{"name":"Houston Veterans Affairs Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA"},{"name":"Department of Medicine, Baylor College of Medicine, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willie","family":"Hamilton","sequence":"additional","affiliation":[{"name":"University of Exeter Medical School, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2873-7421","authenticated-orcid":false,"given":"Georgios","family":"Lyratzopoulos","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Health Behaviour Research Centre, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M","family":"Walter","sequence":"additional","affiliation":[{"name":"Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,10,3]]},"reference":[{"key":"2025121515305294000_9.10.e029143.1","unstructured":"Institute of Medicine . Improving diagnosis in health care, 2015. Available: https:\/\/www.nap.edu\/catalog\/21794\/improving-diagnosis-in-health-care [Accessed 6 Aug 2018]."},{"key":"2025121515305294000_9.10.e029143.2","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmn071"},{"key":"2025121515305294000_9.10.e029143.3","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-7-200610030-00006"},{"key":"2025121515305294000_9.10.e029143.4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","article-title":"Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes","volume":"69","author":"Dobruch","year":"2016","journal-title":"Eur Urol"},{"key":"2025121515305294000_9.10.e029143.5","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.48"},{"key":"2025121515305294000_9.10.e029143.6","first-page":"478","article-title":"Pre-referral general practitioner consultations and subsequent experience of cancer care: evidence from the English cancer patient experience survey","volume":"25","author":"Mendonca","year":"2016","journal-title":"Eur J Cancer Care"},{"key":"2025121515305294000_9.10.e029143.7","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.109"},{"key":"2025121515305294000_9.10.e029143.8","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.23"},{"issue":"Suppl 5","key":"2025121515305294000_9.10.e029143.9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/bju.13821","article-title":"Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review","volume":"119","author":"Ngo","year":"2017","journal-title":"BJU Int"},{"key":"2025121515305294000_9.10.e029143.10","unstructured":"NICE . NICE guidelines [NG12]: Suspected cancer: recognition and referral. Available: http:\/\/www.nice.org.uk\/guidance\/NG12\/ [Accessed 1st September 2018]."},{"key":"2025121515305294000_9.10.e029143.11","doi-asserted-by":"publisher","DOI":"10.1258\/jhsrp.2011.010113"},{"key":"2025121515305294000_9.10.e029143.12","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.68"},{"key":"2025121515305294000_9.10.e029143.13","unstructured":"Critical Appraisal Skills Programme . Casp cohort study checklist, 2017. Available: http:\/\/www.casp-uk.net\/checklists [Accessed 1 Sep 2018]."},{"key":"2025121515305294000_9.10.e029143.14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000363334","article-title":"Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study","volume":"94","author":"Aziz","year":"2015","journal-title":"Urol Int"},{"key":"2025121515305294000_9.10.e029143.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11661.x"},{"key":"2025121515305294000_9.10.e029143.16","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/bjc.2016.265","article-title":"Fast-Track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective: results from a prospective intervention study","volume":"115","author":"Liedberg","year":"2016","journal-title":"Br J Cancer"},{"issue":"Suppl. 3","key":"2025121515305294000_9.10.e029143.17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/bju.13939","article-title":"Delays in the diagnosis and initial treatment of bladder cancer in Western Australia","volume":"120","author":"McCombie","year":"2017","journal-title":"BJU Int"},{"key":"2025121515305294000_9.10.e029143.18","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.urolonc.2008.10.018","article-title":"Are patients with hematuria appropriately referred to urology? A multi-institutional questionnaire based survey","volume":"28","author":"Nieder","year":"2010","journal-title":"Urol Oncol"},{"key":"2025121515305294000_9.10.e029143.19","doi-asserted-by":"crossref","unstructured":"Sell V , Ettala O , Montoya Perez I , et al . Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial. World J Urol 2019;63.doi:10.1007\/s00345-019-02841-4","DOI":"10.1007\/s00345-019-02841-4"},{"key":"2025121515305294000_9.10.e029143.20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1308\/003588410X12518836440207","article-title":"The impact of the two-week wait rule on the diagnosis and management of bladder cancer in a single UK institution","volume":"92","author":"Blick","year":"2010","journal-title":"Ann R Coll Surg Engl"},{"key":"2025121515305294000_9.10.e029143.21","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.juro.2015.10.136","article-title":"Microhematuria in postmenopausal women: adherence to guidelines in a tertiary care setting","volume":"195","author":"Bradley","year":"2016","journal-title":"J Urol"},{"key":"2025121515305294000_9.10.e029143.22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.amjmed.2014.02.013","article-title":"Evaluating hematuria: impact of guideline adherence on urologic cancer diagnosis","volume":"127","author":"Shinagare","year":"2014","journal-title":"Am J Med"},{"key":"2025121515305294000_9.10.e029143.23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.1301"},{"key":"2025121515305294000_9.10.e029143.24","doi-asserted-by":"crossref","first-page":"88.e19","DOI":"10.1016\/j.urolonc.2017.11.004","article-title":"Diagnostic evaluation of patients presenting with hematuria: an electronic health record-based study","volume":"36","author":"Richards","year":"2018","journal-title":"Urol Oncol"},{"key":"2025121515305294000_9.10.e029143.25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.urolonc.2012.07.001","article-title":"What is evaluation of hematuria by primary care physicians? use of electronic medical records to assess practice patterns with intermediate follow-up","volume":"32","author":"Buteau","year":"2014","journal-title":"Urol Oncol"},{"key":"2025121515305294000_9.10.e029143.26","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25310"},{"key":"2025121515305294000_9.10.e029143.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.01.086"},{"key":"2025121515305294000_9.10.e029143.28","doi-asserted-by":"crossref","first-page":"300.e1","DOI":"10.1016\/j.urolonc.2019.01.007","article-title":"Disparities in the diagnostic evaluation of microhematuriaand implications for the detection of urologic malignancy","volume":"37","author":"Matulewicz","year":"2019","journal-title":"Urol Oncol"},{"key":"2025121515305294000_9.10.e029143.29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3747\/co.22.2052","article-title":"Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer","volume":"22","author":"Santos","year":"2015","journal-title":"Current Oncology"},{"key":"2025121515305294000_9.10.e029143.30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/21681805.2018.1498124","article-title":"Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria","volume":"52","author":"Nilbert","year":"2018","journal-title":"Scand J Urol"},{"key":"2025121515305294000_9.10.e029143.31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.urology.2018.08.011","article-title":"Geographic variation in cystoscopy rates for suspected bladder cancer between female and male Medicare beneficiaries","volume":"122","author":"Han","year":"2018","journal-title":"Urology"},{"key":"2025121515305294000_9.10.e029143.32","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.juro.2014.04.101","article-title":"Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis","volume":"192","author":"Garg","year":"2014","journal-title":"Journal of Urology"},{"key":"2025121515305294000_9.10.e029143.33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4338\/ACI-2016-10-RA-0176","article-title":"Application of electronic algorithms to improve diagnostic evaluation for bladder cancer","volume":"26","author":"Murphy","year":"2017","journal-title":"Appl Clin Inform"},{"key":"2025121515305294000_9.10.e029143.34","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.juro.2017.06.083","article-title":"Variation in the diagnostic evaluation among persons with hematuria: influence of gender, race and risk factors for bladder cancer","volume":"198","author":"Ark","year":"2017","journal-title":"J Urol"},{"key":"2025121515305294000_9.10.e029143.35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11606-014-3116-2","article-title":"Gender, race, and variation in the evaluation of microscopic hematuria among Medicare beneficiaries","volume":"30","author":"Bassett","year":"2015","journal-title":"J Gen Intern Med"},{"key":"2025121515305294000_9.10.e029143.36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.amjmed.2014.01.010","article-title":"Variation in the intensity of hematuria evaluation: a target for primary care quality improvement","volume":"127","author":"Friedlander","year":"2014","journal-title":"Am J Med"},{"key":"2025121515305294000_9.10.e029143.37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/bju.13878","article-title":"Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database","volume":"120","author":"Chappidi","year":"2017","journal-title":"BJU Int"},{"key":"2025121515305294000_9.10.e029143.38","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25048"},{"key":"2025121515305294000_9.10.e029143.39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/cncr.28416","article-title":"Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation","volume":"120","author":"Cohn","year":"2014","journal-title":"Cancer"},{"key":"2025121515305294000_9.10.e029143.40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002861","article-title":"Gender inequalities in the promptness of diagnosis of bladder and renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit survey","volume":"3","author":"Lyratzopoulos","year":"2013","journal-title":"BMJ Open"},{"issue":"Suppl 5","key":"2025121515305294000_9.10.e029143.41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/bju.13809","article-title":"Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria","volume":"119","author":"Ngo","year":"2017","journal-title":"BJU Int"},{"key":"2025121515305294000_9.10.e029143.42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/iju.12959","article-title":"Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: implications for sex disparities","volume":"23","author":"Richards","year":"2016","journal-title":"International Journal of Urology"},{"key":"2025121515305294000_9.10.e029143.43","doi-asserted-by":"crossref","unstructured":"Kelly JD , Fawcett DP , Goldberg LC . Assessment and management of non-visible haematuria in primary care. BMJ 2009;338.doi:10.1136\/bmj.a3021","DOI":"10.1136\/bmj.a3021"},{"key":"2025121515305294000_9.10.e029143.44","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp10X515412"},{"key":"2025121515305294000_9.10.e029143.45","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/bjc.2016.304","article-title":"Cancer incidence and mortality projections in the UK until 2035","volume":"115","author":"Smittenaar","year":"2016","journal-title":"Br J Cancer"},{"key":"2025121515305294000_9.10.e029143.46","unstructured":"American Urological Association . Diagnosis, evaluation and follow-up of asymptomatic Microhematuria (AMH) in adults, 2012. Available: http:\/\/www.auanet.org\/guidelines\/asymptomatic-microhematuria-(2012-reviewed-for-currency-2016) [Accessed 1 Sep 2018]."},{"key":"2025121515305294000_9.10.e029143.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.10.004"},{"key":"2025121515305294000_9.10.e029143.48","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/joim.12868","article-title":"Development and validation of a haematuria cancer risk score to identify patients at risk of harbouring cancer","volume":"285","author":"Tan","year":"2019","journal-title":"J Intern Med"},{"key":"2025121515305294000_9.10.e029143.49","first-page":"32","article-title":"Delayed workup of rectal bleeding in adult primary care: examining process-of-care failures","volume":"43","author":"Weingart","year":"2017","journal-title":"Jt Comm J Qual Patient Saf"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-029143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T23:31:04Z","timestamp":1765841464000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-029143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,3]]},"published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1136\/bmjopen-2019-029143"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-029143","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}